These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of the efficacy of intrathecal nimodipine in canine models of chronic cerebral vasospasm. Gioia AE; White RP; Bakhtian B; Robertson JT J Neurosurg; 1985 May; 62(5):721-8. PubMed ID: 3838768 [TBL] [Abstract][Full Text] [Related]
3. Reversal of cerebral arterial spasm by intrathecal administration of a calcium antagonist (nimodipine). Voldby B; Petersen OF; Buhl M; Jakobsen P; Ostergaard R Acta Neurochir (Wien); 1984; 70(3-4):243-54. PubMed ID: 6546832 [TBL] [Abstract][Full Text] [Related]
4. Intracarotid slow bolus injection of nimodipine during angiography for treatment of cerebral vasospasm after SAH. A preliminary report. Grotenhuis JA; Bettag W; Fiebach BJ; Dabir K J Neurosurg; 1984 Aug; 61(2):231-40. PubMed ID: 6737047 [TBL] [Abstract][Full Text] [Related]
5. Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor. Wolf EW; Banerjee A; Soble-Smith J; Dohan FC; White RP; Robertson JT J Neurosurg; 1998 Aug; 89(2):279-88. PubMed ID: 9688124 [TBL] [Abstract][Full Text] [Related]
6. Chronic cerebral vasospasm: effect of volume and timing of hemorrhage in a canine model. Zabramski JM; Spetzler RF; Bonstelle C Neurosurgery; 1986 Jan; 18(1):1-6. PubMed ID: 3945370 [TBL] [Abstract][Full Text] [Related]
7. Immediate postangiographic intraarterial treatment of cerebral vasospasm after subarachnoid hemorrhage with nimodipine. Report on 3 cases. Böker DK; Solymosi L; Wassmann H Neurochirurgia (Stuttg); 1985 May; 28 Suppl 1():118-20. PubMed ID: 4010867 [TBL] [Abstract][Full Text] [Related]
8. Role of calcium antagonists in cerebral arterial spasm. Allen GS Am J Cardiol; 1985 Jan; 55(3):149B-153B. PubMed ID: 3881907 [TBL] [Abstract][Full Text] [Related]
9. Selective intraarterial nimodipine treatment in an experimental subarachnoid hemorrhage model. Firat MM; Gelebek V; Orer HS; Belen D; Firat AK; Balkanci F AJNR Am J Neuroradiol; 2005; 26(6):1357-62. PubMed ID: 15956497 [TBL] [Abstract][Full Text] [Related]
10. The effect of intrathecal sodium nitroprusside on severe chronic vasospasm. Egemen N; Türker RK; Sanlidilek U; Zorlutuna A; Bilgiç S; Baskaya M; Unlü A; Caglar S; Spetzler RF; McCormick JM Neurol Res; 1993 Oct; 15(5):310-5. PubMed ID: 7905604 [TBL] [Abstract][Full Text] [Related]
11. The effects of an intracellular calcium antagonist HA 1077 on delayed cerebral vasospasm in dogs. Shibuya M; Suzuki Y; Takayasu M; Asano T; Harada T; Ikegaki I; Satoh S; Hidaka H Acta Neurochir (Wien); 1988; 90(1-2):53-9. PubMed ID: 3344625 [TBL] [Abstract][Full Text] [Related]
12. Intrathecal nimodipine therapy in a primate model of chronic cerebral vasospasm. Lewis PJ; Weir BK; Nosko MG; Tanabe T; Grace MG Neurosurgery; 1988 Mar; 22(3):492-500. PubMed ID: 3362315 [TBL] [Abstract][Full Text] [Related]
13. Nimodipine and chronic vasospasm in monkeys: Part 1. Clinical and radiological findings. Nosko M; Weir B; Krueger C; Cook D; Norris S; Overton T; Boisvert D Neurosurgery; 1985 Feb; 16(2):129-36. PubMed ID: 3974822 [TBL] [Abstract][Full Text] [Related]
14. Effect of nimodipine, a calcium antagonist, on cerebral vasospasm after subarachnoid hemorrhage in cats. Tanaka K; Gotoh F; Muramatsu F; Fukuuchi Y; Okayasu H; Suzuki N; Kobari M Arzneimittelforschung; 1982; 32(12):1529-34. PubMed ID: 6891592 [TBL] [Abstract][Full Text] [Related]
15. Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage. Allen GS; Ahn HS; Preziosi TJ; Battye R; Boone SC; Boone SC; Chou SN; Kelly DL; Weir BK; Crabbe RA; Lavik PJ; Rosenbloom SB; Dorsey FC; Ingram CR; Mellits DE; Bertsch LA; Boisvert DP; Hundley MB; Johnson RK; Strom JA; Transou CR N Engl J Med; 1983 Mar; 308(11):619-24. PubMed ID: 6338383 [TBL] [Abstract][Full Text] [Related]
16. Nimodipine treatment of ischemic neurological deficits due to cerebral vasospasm after subarachnoid hemorrhage. Clinical results of a multicenter study. Koos WT; Perneczky A; Auer LM; Böker DK; Gaab M; Jaksche H; Kostron H; Meinig G; Muizelaar JP; van der Werf AJ Neurochirurgia (Stuttg); 1985 May; 28 Suppl 1():114-7. PubMed ID: 4010866 [TBL] [Abstract][Full Text] [Related]
17. Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm. Wanebo JE; Arthur AS; Louis HG; West K; Kassell NF; Lee KS; Helm GA Neurosurgery; 1998 Dec; 43(6):1409-17; discussion 1417-8. PubMed ID: 9848855 [TBL] [Abstract][Full Text] [Related]
18. [Effect of dilazep on experimental vasospasm--evaluation of angiographical vasospasm and cerebral blood flow]. Yamakawa K; Sasaki T; Saito I; Takakura K No To Shinkei; 1990 Jul; 42(7):669-73. PubMed ID: 2223263 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage. Seifert V; Eisert WG; Stolke D; Goetz C Neurosurgery; 1989 Oct; 25(4):590-8. PubMed ID: 2507953 [TBL] [Abstract][Full Text] [Related]
20. Cerebral vasospasm in a double-injection model in rabbit. Spallone A; Pastore FS Surg Neurol; 1989 Dec; 32(6):408-17. PubMed ID: 2636794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]